Patent Assignment
Reel/Frame 044949/0634
Notice of Grant of Security Interest in Intellectual Property
Recorded: 2017-12-22
Pages: 15
Assignor
OCERA THERAPEUTICS, INC.
Executed: 2017-12-22
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties
(37)
Bending Device for Hollow Double-Structured Pipe
Patent:
5,749,255 →
Application:
08/761,829 →
Trailer Landing Gear Device
Patent:
6,010,154 →
Application:
08/940,757 →
Aluminosilicate Glass for Flat Display Device
Patent:
6,087,284 →
Application:
09/084,252 →
Optically Amplifying Device with Gain Equalizing Function
Patent:
6,144,488 →
Application:
09/265,556 →
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent:
7,169,899 →
Application:
09/679,331 →
Macrocyclic Antagonists of the Motilin Receptor
Spatially-Defined Macrocycles Incorporating Peptide Bond Surrogates
Conformationally-Controlled Biologically Active Macrocyclic Small Molecules as Motilin Antagonists or Ghrelin Agonists
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Macrocyclic Modulators of the Ghrelin Receptor
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Methods of Using Macrocyclic Agonists of the Ghrelin Receptor for Treatment of Gastrointestinal Motility Disorders
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Spatially-Defined Macrocyclic Compounds Useful for Drug Discovery
Intermediates for Macrocyclic Compounds
Processes for Intermediates for Macrocyclic Compounds
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Pharmaceutical Salts of Macrocyclic Modulators of the Ghrelin Receptor
Macrocyclic Antagonists of the Motilin Receptor for Treatment of Gastrointestinal Dysmotility Disorders
Spatially-Defined Macrocycles Incorporating Peptide Bond Surrogates
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Patent:
42,624 →
Application:
12/635,871 →
Macrocyclic Modulators of the Ghrelin Receptor
Patent:
42,013 →
Application:
12/636,048 →
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Spatially-Defined Macrocyclic Compounds Useful for Drug Discovery
Processes for Intermediates for Macrocyclic Compounds
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Macrocyclic Modulators of the Ghrelin Receptor
Methods of Making L-Ornithine Phenyl Acetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Macrocyclic Modulators of the Ghrelin Receptor
Methods of Making L-Ornithine Phenyl Acetate
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 044949, Frame 0634
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0460 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →